These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 10903986

  • 21. Activation of group II metabotropic glutamate receptors results in long-term potentiation following preconditioning stimulation in the dentate gyrus.
    Rush AM, Wu J, Rowan MJ, Anwyl R.
    Neuroscience; 2001; 105(2):335-41. PubMed ID: 11672601
    [Abstract] [Full Text] [Related]

  • 22. Role of spinal metabotropic glutamate receptor subtype 5 in the development of tolerance to morphine-induced antinociception in rat.
    Xu T, Jiang W, Du D, Xu Y, Hu Q, Shen Q.
    Neurosci Lett; 2007 Jun 13; 420(2):155-9. PubMed ID: 17512115
    [Abstract] [Full Text] [Related]

  • 23. LY354740 affects startle responding but not sensorimotor gating or discriminative effects of phencyclidine.
    Schreiber R, Lowe D, Voerste A, De Vry J.
    Eur J Pharmacol; 2000 Jan 28; 388(2):R3-4. PubMed ID: 10666513
    [Abstract] [Full Text] [Related]

  • 24. Increased efficacy of micro-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL/6 mice: comparison with (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959).
    Fischer BD, Miller LL, Henry FE, Picker MJ, Dykstra LA.
    Psychopharmacology (Berl); 2008 Jun 28; 198(2):271-8. PubMed ID: 18392754
    [Abstract] [Full Text] [Related]

  • 25. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.
    Marek GJ, Wright RA, Schoepp DD, Monn JA, Aghajanian GK.
    J Pharmacol Exp Ther; 2000 Jan 28; 292(1):76-87. PubMed ID: 10604933
    [Abstract] [Full Text] [Related]

  • 26. Changes in rat serum corticosterone after treatment with metabotropic glutamate receptor agonists or antagonists.
    Johnson MP, Kelly G, Chamberlain M.
    J Neuroendocrinol; 2001 Aug 28; 13(8):670-7. PubMed ID: 11489083
    [Abstract] [Full Text] [Related]

  • 27. Effects of mGlu1 and mGlu5 metabotropic glutamate antagonists to reverse morphine tolerance in mice.
    Smith FL, Smith PA, Dewey WL, Javed RR.
    Eur J Pharmacol; 2004 May 25; 492(2-3):137-42. PubMed ID: 15178357
    [Abstract] [Full Text] [Related]

  • 28. In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats.
    Battaglia G, Monn JA, Schoepp DD.
    Neurosci Lett; 1997 Jul 04; 229(3):161-4. PubMed ID: 9237483
    [Abstract] [Full Text] [Related]

  • 29. Memantine and dizocilpine interactions with antinociceptive or discriminative stimulus effects of morphine in rats after acute or chronic treatment with morphine.
    Chen Y, Evola M, Young AM.
    Psychopharmacology (Berl); 2013 Jan 04; 225(1):187-99. PubMed ID: 22864944
    [Abstract] [Full Text] [Related]

  • 30. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
    Cartmell J, Monn JA, Schoepp DD.
    J Pharmacol Exp Ther; 1999 Oct 04; 291(1):161-70. PubMed ID: 10490900
    [Abstract] [Full Text] [Related]

  • 31. The anxiolytic action of mGlu2/3 receptor agonist, LY354740, in the fear-potentiated startle model in rats is mechanistically distinct from diazepam.
    Tizzano JP, Griffey KI, Schoepp DD.
    Pharmacol Biochem Behav; 2002 Sep 04; 73(2):367-74. PubMed ID: 12117591
    [Abstract] [Full Text] [Related]

  • 32. Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval.
    Belozertseva IV, Dravolina OA, Neznanova ON, Danysz W, Bespalov AY.
    Eur J Pharmacol; 2000 May 19; 396(2-3):77-83. PubMed ID: 10822059
    [Abstract] [Full Text] [Related]

  • 33. Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia.
    Lam AG, Soriano MA, Monn JA, Schoepp DD, Lodge D, McCulloch J.
    Neurosci Lett; 1998 Sep 25; 254(2):121-3. PubMed ID: 9779935
    [Abstract] [Full Text] [Related]

  • 34. Effects of the group II metabotropic glutamate receptor agonist, LY354740 on schedule-controlled behaviour in rats.
    Moore NA, Rees G, Monn JA.
    Behav Pharmacol; 1999 May 25; 10(3):319-25. PubMed ID: 10780246
    [Abstract] [Full Text] [Related]

  • 35. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
    Danysz W, Kozela E, Parsons CG, Sladek M, Bauer T, Popik P.
    Neuropharmacology; 2005 Mar 25; 48(3):360-71. PubMed ID: 15721168
    [Abstract] [Full Text] [Related]

  • 36. Reversal of novelty-induced hyperlocomotion and hippocampal c-Fos expression in GluA1 knockout male mice by the mGluR2/3 agonist LY354740.
    Procaccini C, Maksimovic M, Aitta-Aho T, Korpi ER, Linden AM.
    Neuroscience; 2013 Oct 10; 250():189-200. PubMed ID: 23867766
    [Abstract] [Full Text] [Related]

  • 37. In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain.
    Schaffhauser H, Richards JG, Cartmell J, Chaboz S, Kemp JA, Klingelschmidt A, Messer J, Stadler H, Woltering T, Mutel V.
    Mol Pharmacol; 1998 Feb 10; 53(2):228-33. PubMed ID: 9463480
    [Abstract] [Full Text] [Related]

  • 38. Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat.
    Redwine KE, Trujillo KA.
    Pharmacol Biochem Behav; 2003 Sep 10; 76(2):361-72. PubMed ID: 14592689
    [Abstract] [Full Text] [Related]

  • 39. The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal.
    Vandergriff J, Rasmussen K.
    Neuropharmacology; 1999 Feb 10; 38(2):217-22. PubMed ID: 10218862
    [Abstract] [Full Text] [Related]

  • 40. Selective group II glutamate metabotropic receptor agonist LY354740 attenuates pentetrazole- and picrotoxin-induced seizures.
    Kłodzińska A, Chojnacka-Wójcik E, Pilc A.
    Pol J Pharmacol; 1999 Feb 10; 51(6):543-5. PubMed ID: 10817535
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.